Comparison of the Absorb bioresorbable vascular scaffold to the Xience durable polymer everolimus-eluting metallic stent in routine clinical practice: a propensity score-matched analysis from a multicenter registry

INTRODUCTION: Most clinical trials related to bioresorbable vascular scaffold (BVS) technology are limited to a highly selected patient population. AIM: To evaluate early and long-term clinical outcomes of the Absorb everolimus-eluting BVS compared to the everolimus-eluting metallic XIENCE V stent i...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlik, Bartłomiej, Milewski, Krzysztof, Derbisz, Kamil, Jelonek, Michał, Chrząszcz, Patrycja, Beil, Sonia, Młodziankowski, Adam, Picheta, Wojciech, Buszman, Piotr P., Buszman, Paweł E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041836/
https://www.ncbi.nlm.nih.gov/pubmed/30008767
http://dx.doi.org/10.5114/aic.2018.76406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041836/
https://www.ncbi.nlm.nih.gov/pubmed/30008767
http://dx.doi.org/10.5114/aic.2018.76406

Ejemplares similares